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Abstract
A 69 y/o woman with a history of primary diffuse large B cell lymphoma in the right thigh muscle was referred for recurrence 
evaluation with 18F-FDG PET/CT. After routine courses of chemoradiation, MRI was done in order to evaluate treatment response 
with inconclusive findings. 18FDG PET/CT revealed abnormal uptake in the primary site of the disease as well as secondary 
involvement of stomach, pancreas, pelvic lymph nodes, and both tibiae. Our case showed the importance of 18F-FDG PET/CT 
in the detection of unusual soft tissue extension of lymphoma.
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Introduction
Diffuse large B cell lymphoma (DLBCL) is the most common 
subtype of non-Hodgkin’s lymphomas (NHL) [1], which usually 
arises from lymph nodes. It can also have an extra-nodal origin 
in approximately 30–40% of the cases [2]. The most common 
extra-nodal sites are testis, skin, lung, bone, central nervous sys-
tem, respiratory and gastrointestinal tracts [3]. Primary skeletal 
muscle involvement is very rare [1–3]. It has also been reported 
that upper extremities and gluteal muscle involvements are more 
predominantly affected [1]. In muscular lymphoma which usually 
is FDG avid, diffuse enlargement or focal intramuscular mass are 
seen [4]. Bone involvement is not common [5] and secondary 
involvement of the pancreas is very rare [6]. In the present case 
report, we described an unusual pattern of primary skeletal muscle 
NHL detected by whole body 18F-FDG PET/CT.
Case report
A 69-year-old woman with a history of DLBCL within the 
right thigh muscles had been treated with chemoradiation. She 
experienced no pain in the involved region. The patient under-
went MRI for response evaluation. MRI results were inconclusive 
and couldn’t differentiate between post-radiation changes and 
residual disease. She was referred for more assessment with 
18F-FDG PET/CT. Whole body MIP image revealed multiple foci 
of increased FDG uptake in the right thigh, stomach, pancreas, 
pelvic lymph nodes and both tibiae (Fig. 1A). The axial im-
ages demonstrated increased FDG uptake throughout the right 
thigh muscles (Fig. 1B–D). Also, abnormal FDG uptake was noted 
in the thickened stomach wall (Fig. 1E–G) with SUVmax of 16.91 
and pancreatic body and tail (Fig. 1H–J) with SUVmax of 17.79 
which were in favor of secondary extranodal involvement. No further 
follow up scan was acquired.
Discussion
Although the secondary extranodal disease is common in 
lymphoma, it rarely occurs as a primary site of lymphoma [9]. 
Primary skeletal muscle involvement occurs in only 0.1% of all 
lymphomas [7]. In addition, the pancreas is rarely involved by 
lymphoma [6]. Although the stomach is the most common site 
of involvement as the primary extra-nodal site or secondary to 
disseminated nodal disease [7], majority of secondary gastric 
NHL couldn’t be detected by conventional diagnostic meth-
ods [8].18F-FDG PET/CT is a valuable diagnostic test for identify-
ing extranodal sites involvement in lymphoma staging, treatment 
response or recurrence evaluation [8, 9] and it is more sensitive 
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and specific than conventional imaging for assessment of disease 
extension [10, 11]. Here, we showed an unusual pattern of NHL 
by emphasizing the role of 18F-FDG PET/CT in the differentiation 
of recurrence from post-radiation changes, as well as showing the 
extension of the disease.
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Figure 1. The Whole body MIP image showed multiple foci of increased FDG uptake in the right thigh, stomach, pancreas, pelvic lymph nodes 
and both tibiae (A); The axial images demonstrated increased FDG uptake throughout the right thigh muscles (B–D); stomach wall (E–G) and 
pancreatic body and tail (H–J) 
